Journals / Turkish Journal of Gastroenterology / 2012 / Cilt: 23 - Sayı: 5

Otoimmün karaciğer sirozunda siklosporin kurtarma tedavisi: Olgu sunumu

Cyclosporine rescue therapy in autoimmune liver cirrhosis: A case report

Pages
599–603
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We conclude that cyclosporine seems to be an effective alternative to azathioprine as a steroid-sparing agent in both non-cirrhotic and cirrhotic autoimmune hepatitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Autoimmune hepatitis is an inflammatory condition of the liver that can lead to significant morbidity and mortality.
📊
Key Findings & Data:However, long-term use of corticosteroids and use of azathioprine could be associated with significant adverse effects that prevent their continued use at optimal dosages or may even require complete cessation.
💡
Conclusion & Impact:We conclude that cyclosporine seems to be an effective alternative to azathioprine as a steroid-sparing agent in both non-cirrhotic and cirrhotic autoimmune hepatitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Autoimmune hepatitis is an inflammatory condition of the liver that can lead to significant morbidity and mortality. Corticosteroids with or without azathioprine have been shown to improve outcome and are the current standard of care in autoimmune hepatitis patients. However, long-term use of corticosteroids and use of azathioprine could be associated with significant adverse effects that prevent their continued use at optimal dosages or may even require complete cessation. We present a patient with autoimmune liver cirrhosis who was intolerant of corticosteroid and azathioprine, who was successfully treated with cyclosporine. To our knowledge, cyclosporine use has not been reported previously in autoimmune cirrhosis, although it has been used in autoimmune hepatitis patients with reported success and good tolerability. We conclude that cyclosporine seems to be an effective alternative to azathioprine as a steroid-sparing agent in both non-cirrhotic and cirrhotic autoimmune hepatitis. Top

Özet

Otoimmün hepatit, karaciğerde önemli düzeyde morbidite ve mortaliteye neden olabilen iltihabi bir durumdur. Otoimmün hepatit hastalarında, azatioprinle birlikte veya yalnız başına kullanılan kortikosteroidler sonuçları iyileştirerek şimdiki standart tedaviyi oluşturmaktadır. Ancak kortikosteroidler ve azatioprinin uzun dönem kullanılması, optimal dozda devamlı kullanılmasını engelleyen ve hatta tamamen kesilmesini gerektiren ciddi yan etkilere neden olabilmektedir. Kortikosteroid ve azatioprin intoleransı olan ve siklosporinle başarılı şekilde tedavi edilen otoimmün karaciğer sirozlu bir hastayı sunuyoruz. Otoimmün hepatitli hastalarda siklosporinin başarıyla ve iyi tolerabilite ile kullanımı bildirilmiş olsa da, bildiğimiz kadarıyla otoimmün sirozda kullanılması daha önce rapor edilmemiştir. Sonuçta, sirotik ve sirotik olmayan otoimmün hepatitli hastalarda siklosporin, azatioprin etkin bir alternatif steroid sparing ajan olarak görünmektedir.

🔖

Cite This Article

WAH-KHEONG, C., JAGANATHAN, V., SANJIV, M. (2012). Otoimmün karaciğer sirozunda siklosporin kurtarma tedavisi: Olgu sunumu. Turkish Journal of Gastroenterology, Cilt: 23 - Sayı: 5, 599–603. https://ajindex.com/articles/410784

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38
  2. Mistilis SP, Skyring AP, Blackburn CR. Natural history of active chronic hepatitis. Clinical features, course, diagnostic criteria, morbidity, mortality and survival. Australas Ann Med 1968; 17: 214-23
  3. Soloway RD, Summerskill WH, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972; 63: 820-33
  4. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971; 40: 159-85
  5. Murray-Lyon IM, Stern RB, Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1973; 1: 735-7
  6. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-213
  7. Hyams JS, Ballow M, Leichtner AM. Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterology 1987; 93: 890-3
  8. Debray D, Maggiore G, Girardet JP, et al. Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis. J Pediatr 1999; 135: 111-4
  9. Alvarez F, Ciocca M, Canero-Velasco C, et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999; 30: 222-7
  10. Cuarterolo M, Ciocca M, Velasco CC, et al. Follow-up of children with autoimmune hepatitis treated with cyclosporine. J Pediatr Gastroenterol Nutr 2006; 43: 635-9
  11. Sciveres M, Caprai S, Palla G, et al. Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents. Aliment Pharmacol Ther 2004; 19: 209-17
  12. Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, et al. Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001; 46: 1321-7
  13. Mistilis SP, Vickers CR, Darroch MH, McCarthy SW. Cyclosporin, a new treatment for autoimmune chronic active hepatitis. Med J Aust 1985; 143: 463-5
  14. Jackson LD, Song E. Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis. Gut 1995; 36: 459-61
  15. Summerskill WH, Korman MG, Ammon HV, Baggenstoss AH. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975; 16: 876-83